| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |